Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Deghor-120 Degarelix 120mg Injection:
Deghor-120 Degarelix 120mg Injection is an advanced hormonal therapy designed for the treatment of advanced prostate cancer. This medication functions by lowering the levels of testosterone, a hormone that contributes to the growth and spread of prostate cancer cells. Deghor-120 is a trusted option for managing prostate cancer, aiming to control the disease and enhance patient outcomes.
Uses of Deghor-120 Degarelix 120mg Injection:
Advanced Prostate Cancer: Effective in treating advanced prostate cancer by reducing testosterone levels.
Hormone Therapy: Used as part of hormone therapy to manage prostate cancer and slow its progression.
Disease Control: Helps in controlling the symptoms and progression of prostate cancer.
Benefits of Deghor-120 Degarelix 120mg Injection:
Effective Hormonal Control: Lowers testosterone levels to slow the growth of prostate cancer cells.
Rapid Action: Begins to reduce testosterone levels quickly, providing fast therapeutic effects.
Non-Surgical Option: Offers a non-surgical alternative for managing advanced prostate cancer.
Improved Quality of Life: Helps in controlling cancer-related symptoms, improving the patient's quality of life.
Mechanism of Deghor-120 Degarelix 120mg Injection:
Deghor-120 works by binding to and blocking the gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland. This action inhibits the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn reduces the production of testosterone by the testes. Since testosterone stimulates the growth of prostate cancer cells, lowering its levels helps to slow down or stop the progression of the disease. Deghor-120 achieves a rapid and sustained reduction in testosterone levels, making it an effective option for managing advanced prostate cancer.